Click for best price
Gene Therapy For Heart Failure Market Size, Share 2023
Gene therapy provides a novel strategy for targeting abnormalities in heart cells that adversely affect heart function.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy For Heart Failure, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy For Heart Failure. This report contains market size and forecasts of Gene Therapy For Heart Failure in global, including the following market information:
Global Gene Therapy For Heart Failure Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Gene Therapy For Heart Failure market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Gene Modification Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Gene Therapy For Heart Failure include Askbio, RENOVACORINC, Uniqure, DINAQOR, PRECIGEN, Heartseed, Cardior, NOVARTIS and Blue Rock, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Therapy For Heart Failure companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapy For Heart Failure Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Gene Therapy For Heart Failure Market Segment Percentages, by Type, 2022 (%)
Gene Modification
Gene Replacement
Others
Global Gene Therapy For Heart Failure Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Gene Therapy For Heart Failure Market Segment Percentages, by Application, 2022 (%)
Hospital
Laboratory
Others
Global Gene Therapy For Heart Failure Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Gene Therapy For Heart Failure Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Therapy For Heart Failure revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene Therapy For Heart Failure revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Askbio
RENOVACORINC
Uniqure
DINAQOR
PRECIGEN
Heartseed
Cardior
NOVARTIS
Blue Rock
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Therapy For Heart Failure, market overview.
Chapter 2: Global Gene Therapy For Heart Failure market size in revenue.
Chapter 3: Detailed analysis of Gene Therapy For Heart Failure company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Therapy For Heart Failure in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Gene Therapy For Heart Failure Market, Global Outlook and Forecast 2023-2035 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gene Therapy For Heart Failure Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapy For Heart Failure Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy For Heart Failure Overall Market Size
2.1 Global Gene Therapy For Heart Failure Market Size: 2022 VS 2035
2.2 Global Gene Therapy For Heart Failure Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Therapy For Heart Failure Players in Global Market
3.2 Top Global Gene Therapy For Heart Failure Companies Ranked by Revenue
3.3 Global Gene Therapy For Heart Failure Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy For Heart Failure Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene Therapy For Heart Failure Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy For Heart Failure Players in Global Market
3.6.1 List of Global Tier 1 Gene Therapy For Heart Failure Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy For Heart Failure Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Therapy For Heart Failure Market Size Markets, 2022 & 2035
4.1.2 Gene Modification
4.1.3 Gene Replacement
4.1.4 Others
4.2 By Type - Global Gene Therapy For Heart Failure Revenue & Forecasts
4.2.1 By Type - Global Gene Therapy For Heart Failure Revenue, 2018-2023
4.2.2 By Type - Global Gene Therapy For Heart Failure Revenue, 2024-2035
4.2.3 By Type - Global Gene Therapy For Heart Failure Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Therapy For Heart Failure Market Size, 2022 & 2035
5.1.2 Hospital
5.1.3 Laboratory
5.1.4 Others
5.2 By Application - Global Gene Therapy For Heart Failure Revenue & Forecasts
5.2.1 By Application - Global Gene Therapy For Heart Failure Revenue, 2018-2023
5.2.2 By Application - Global Gene Therapy For Heart Failure Revenue, 2024-2035
5.2.3 By Application - Global Gene Therapy For Heart Failure Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Gene Therapy For Heart Failure Market Size, 2022 & 2035
6.2 By Region - Global Gene Therapy For Heart Failure Revenue & Forecasts
6.2.1 By Region - Global Gene Therapy For Heart Failure Revenue, 2018-2023
6.2.2 By Region - Global Gene Therapy For Heart Failure Revenue, 2024-2035
6.2.3 By Region - Global Gene Therapy For Heart Failure Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Gene Therapy For Heart Failure Revenue, 2018-2035
6.3.2 US Gene Therapy For Heart Failure Market Size, 2018-2035
6.3.3 Canada Gene Therapy For Heart Failure Market Size, 2018-2035
6.3.4 Mexico Gene Therapy For Heart Failure Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Gene Therapy For Heart Failure Revenue, 2018-2035
6.4.2 Germany Gene Therapy For Heart Failure Market Size, 2018-2035
6.4.3 France Gene Therapy For Heart Failure Market Size, 2018-2035
6.4.4 U.K. Gene Therapy For Heart Failure Market Size, 2018-2035
6.4.5 Italy Gene Therapy For Heart Failure Market Size, 2018-2035
6.4.6 Russia Gene Therapy For Heart Failure Market Size, 2018-2035
6.4.7 Nordic Countries Gene Therapy For Heart Failure Market Size, 2018-2035
6.4.8 Benelux Gene Therapy For Heart Failure Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Gene Therapy For Heart Failure Revenue, 2018-2035
6.5.2 China Gene Therapy For Heart Failure Market Size, 2018-2035
6.5.3 Japan Gene Therapy For Heart Failure Market Size, 2018-2035
6.5.4 South Korea Gene Therapy For Heart Failure Market Size, 2018-2035
6.5.5 Southeast Asia Gene Therapy For Heart Failure Market Size, 2018-2035
6.5.6 India Gene Therapy For Heart Failure Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Gene Therapy For Heart Failure Revenue, 2018-2035
6.6.2 Brazil Gene Therapy For Heart Failure Market Size, 2018-2035
6.6.3 Argentina Gene Therapy For Heart Failure Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Therapy For Heart Failure Revenue, 2018-2035
6.7.2 Turkey Gene Therapy For Heart Failure Market Size, 2018-2035
6.7.3 Israel Gene Therapy For Heart Failure Market Size, 2018-2035
6.7.4 Saudi Arabia Gene Therapy For Heart Failure Market Size, 2018-2035
6.7.5 UAE Gene Therapy For Heart Failure Market Size, 2018-2035
7 Gene Therapy For Heart Failure Companies Profiles
7.1 Askbio
7.1.1 Askbio Company Summary
7.1.2 Askbio Business Overview
7.1.3 Askbio Gene Therapy For Heart Failure Major Product Offerings
7.1.4 Askbio Gene Therapy For Heart Failure Revenue in Global Market (2018-2023)
7.1.5 Askbio Key News & Latest Developments
7.2 RENOVACORINC
7.2.1 RENOVACORINC Company Summary
7.2.2 RENOVACORINC Business Overview
7.2.3 RENOVACORINC Gene Therapy For Heart Failure Major Product Offerings
7.2.4 RENOVACORINC Gene Therapy For Heart Failure Revenue in Global Market (2018-2023)
7.2.5 RENOVACORINC Key News & Latest Developments
7.3 Uniqure
7.3.1 Uniqure Company Summary
7.3.2 Uniqure Business Overview
7.3.3 Uniqure Gene Therapy For Heart Failure Major Product Offerings
7.3.4 Uniqure Gene Therapy For Heart Failure Revenue in Global Market (2018-2023)
7.3.5 Uniqure Key News & Latest Developments
7.4 DINAQOR
7.4.1 DINAQOR Company Summary
7.4.2 DINAQOR Business Overview
7.4.3 DINAQOR Gene Therapy For Heart Failure Major Product Offerings
7.4.4 DINAQOR Gene Therapy For Heart Failure Revenue in Global Market (2018-2023)
7.4.5 DINAQOR Key News & Latest Developments
7.5 PRECIGEN
7.5.1 PRECIGEN Company Summary
7.5.2 PRECIGEN Business Overview
7.5.3 PRECIGEN Gene Therapy For Heart Failure Major Product Offerings
7.5.4 PRECIGEN Gene Therapy For Heart Failure Revenue in Global Market (2018-2023)
7.5.5 PRECIGEN Key News & Latest Developments
7.6 Heartseed
7.6.1 Heartseed Company Summary
7.6.2 Heartseed Business Overview
7.6.3 Heartseed Gene Therapy For Heart Failure Major Product Offerings
7.6.4 Heartseed Gene Therapy For Heart Failure Revenue in Global Market (2018-2023)
7.6.5 Heartseed Key News & Latest Developments
7.7 Cardior
7.7.1 Cardior Company Summary
7.7.2 Cardior Business Overview
7.7.3 Cardior Gene Therapy For Heart Failure Major Product Offerings
7.7.4 Cardior Gene Therapy For Heart Failure Revenue in Global Market (2018-2023)
7.7.5 Cardior Key News & Latest Developments
7.8 NOVARTIS
7.8.1 NOVARTIS Company Summary
7.8.2 NOVARTIS Business Overview
7.8.3 NOVARTIS Gene Therapy For Heart Failure Major Product Offerings
7.8.4 NOVARTIS Gene Therapy For Heart Failure Revenue in Global Market (2018-2023)
7.8.5 NOVARTIS Key News & Latest Developments
7.9 Blue Rock
7.9.1 Blue Rock Company Summary
7.9.2 Blue Rock Business Overview
7.9.3 Blue Rock Gene Therapy For Heart Failure Major Product Offerings
7.9.4 Blue Rock Gene Therapy For Heart Failure Revenue in Global Market (2018-2023)
7.9.5 Blue Rock Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gene Therapy For Heart Failure Market Opportunities & Trends in Global Market
Table 2. Gene Therapy For Heart Failure Market Drivers in Global Market
Table 3. Gene Therapy For Heart Failure Market Restraints in Global Market
Table 4. Key Players of Gene Therapy For Heart Failure in Global Market
Table 5. Top Gene Therapy For Heart Failure Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gene Therapy For Heart Failure Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gene Therapy For Heart Failure Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gene Therapy For Heart Failure Product Type
Table 9. List of Global Tier 1 Gene Therapy For Heart Failure Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy For Heart Failure Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gene Therapy For Heart Failure Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Gene Therapy For Heart Failure Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gene Therapy For Heart Failure Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Gene Therapy For Heart Failure Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Gene Therapy For Heart Failure Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gene Therapy For Heart Failure Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Gene Therapy For Heart Failure Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Gene Therapy For Heart Failure Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gene Therapy For Heart Failure Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gene Therapy For Heart Failure Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gene Therapy For Heart Failure Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gene Therapy For Heart Failure Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gene Therapy For Heart Failure Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gene Therapy For Heart Failure Revenue, (US$, Mn), 2024-2035
Table 30. Askbio Company Summary
Table 31. Askbio Gene Therapy For Heart Failure Product Offerings
Table 32. Askbio Gene Therapy For Heart Failure Revenue (US$, Mn) & (2018-2023)
Table 33. Askbio Key News & Latest Developments
Table 34. RENOVACORINC Company Summary
Table 35. RENOVACORINC Gene Therapy For Heart Failure Product Offerings
Table 36. RENOVACORINC Gene Therapy For Heart Failure Revenue (US$, Mn) & (2018-2023)
Table 37. RENOVACORINC Key News & Latest Developments
Table 38. Uniqure Company Summary
Table 39. Uniqure Gene Therapy For Heart Failure Product Offerings
Table 40. Uniqure Gene Therapy For Heart Failure Revenue (US$, Mn) & (2018-2023)
Table 41. Uniqure Key News & Latest Developments
Table 42. DINAQOR Company Summary
Table 43. DINAQOR Gene Therapy For Heart Failure Product Offerings
Table 44. DINAQOR Gene Therapy For Heart Failure Revenue (US$, Mn) & (2018-2023)
Table 45. DINAQOR Key News & Latest Developments
Table 46. PRECIGEN Company Summary
Table 47. PRECIGEN Gene Therapy For Heart Failure Product Offerings
Table 48. PRECIGEN Gene Therapy For Heart Failure Revenue (US$, Mn) & (2018-2023)
Table 49. PRECIGEN Key News & Latest Developments
Table 50. Heartseed Company Summary
Table 51. Heartseed Gene Therapy For Heart Failure Product Offerings
Table 52. Heartseed Gene Therapy For Heart Failure Revenue (US$, Mn) & (2018-2023)
Table 53. Heartseed Key News & Latest Developments
Table 54. Cardior Company Summary
Table 55. Cardior Gene Therapy For Heart Failure Product Offerings
Table 56. Cardior Gene Therapy For Heart Failure Revenue (US$, Mn) & (2018-2023)
Table 57. Cardior Key News & Latest Developments
Table 58. NOVARTIS Company Summary
Table 59. NOVARTIS Gene Therapy For Heart Failure Product Offerings
Table 60. NOVARTIS Gene Therapy For Heart Failure Revenue (US$, Mn) & (2018-2023)
Table 61. NOVARTIS Key News & Latest Developments
Table 62. Blue Rock Company Summary
Table 63. Blue Rock Gene Therapy For Heart Failure Product Offerings
Table 64. Blue Rock Gene Therapy For Heart Failure Revenue (US$, Mn) & (2018-2023)
Table 65. Blue Rock Key News & Latest Developments
List of Figures
Figure 1. Gene Therapy For Heart Failure Segment by Type in 2022
Figure 2. Gene Therapy For Heart Failure Segment by Application in 2022
Figure 3. Global Gene Therapy For Heart Failure Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene Therapy For Heart Failure Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Gene Therapy For Heart Failure Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy For Heart Failure Revenue in 2022
Figure 8. By Type - Global Gene Therapy For Heart Failure Revenue Market Share, 2018-2035
Figure 9. By Application - Global Gene Therapy For Heart Failure Revenue Market Share, 2018-2035
Figure 10. By Type - Global Gene Therapy For Heart Failure Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Gene Therapy For Heart Failure Revenue Market Share, 2018-2035
Figure 12. By Application - Global Gene Therapy For Heart Failure Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Gene Therapy For Heart Failure Revenue Market Share, 2018-2035
Figure 14. By Region - Global Gene Therapy For Heart Failure Revenue Market Share, 2018-2035
Figure 15. By Country - North America Gene Therapy For Heart Failure Revenue Market Share, 2018-2035
Figure 16. US Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Gene Therapy For Heart Failure Revenue Market Share, 2018-2035
Figure 20. Germany Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 21. France Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Gene Therapy For Heart Failure Revenue Market Share, 2018-2035
Figure 28. China Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 32. India Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Gene Therapy For Heart Failure Revenue Market Share, 2018-2035
Figure 34. Brazil Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Gene Therapy For Heart Failure Revenue Market Share, 2018-2035
Figure 37. Turkey Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Gene Therapy For Heart Failure Revenue, (US$, Mn), 2018-2035
Figure 41. Askbio Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. RENOVACORINC Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Uniqure Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. DINAQOR Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. PRECIGEN Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Heartseed Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cardior Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. NOVARTIS Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Blue Rock Gene Therapy For Heart Failure Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
